Geneva, June 8 -- International Clinical Trials Registry received information related to the study (TCTR20260530009) titled 'Continuous versus extended infusion of meropenem in pediatric sepsis' on May 30.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Faculty of Pharmacy Universitas Indonesia

Condition: Sepsis in children Pediatric sepsis, sepsis, septic shock, meropenem, beta-lactam antibiotics, continuous infusion, extended infusion, pediatric intensive care unit, randomized controlled trial Pediatric sepsis, sepsis, septic shock, meropenem, beta-lactam antibiotics, continuous infusion, extended infusion, pediatric intensive care unit, randomized controlled trial

Intervention: Meropenem 40 mg/kg/dose (max...